» Articles » PMID: 30048168

RETINAL MICROVASCULATURE ALTERATION IN ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY

Overview
Journal Endocr Pract
Specialty Endocrinology
Date 2018 Jul 27
PMID 30048168
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: It is uncertain whether there is an increased retinal vessel density in patients with thyroid-associated ophthalmology (TAO), or if ocular hemodynamic changes are associated with their vision. Many techniques have been applied to analyze ocular hemodynamic changes in TAO patients; however, they suffer from limitations. Optical coherence tomography angiography (OCTA) is more sensitive to hemodynamic changes. We performed OCTA to determine whether there is an increased retinal vessel density in TAO patients, and investigate associations with their vision.

Methods: Twenty TAO patients (right eye) and 20 normal controls (right eye) were recruited for the study. Three-dimensional OCTA images were generated with 6 × 6-mm angiographic OCT scans of the superficial retinal layer (SRL) and deeper retinal layer (DRL) of the macular retina for each eye. We calculated the microvascular (MIR) and macrovascular (MAR) densities and compared MIR, MAR, and total MIR (TMI) density in the healthy control and TAO groups separately. We used the annular partition (C1-C6) and quadrant partition method to analyze retinal vessel density alterations. Correlation analyses were used to examine the association of MIR density and visual acuity.

Results: In the SRL, STMI (superficial TMI) and SMIR (superficial MIR) density increased in the macular area of TAO patients ( P<.05). For the DRL, the density of DMIR (deeper MIR) increased in macular area only ( P<.05). However, with the annular partition method, TAO patients showed significantly increased SMIR density in the C1 and C2 regions ( P<.05), and increased DMIR density only in the C1 region ( P<.05). In the SRL, the correlation coefficient of the STMI/SMIR density in the TAO group was -0.538 ( r = -0.538, P = .032), and visual acuity was -0.624 ( r = -0.624, P = .010).

Conclusion: OCTA findings suggest that active TAO patients present with an increased retinal MIR density. Moreover, increased macular STMI and SMIR density might affect visual acuity.

Abbreviations: CDI = color Doppler imaging; DMIR = deeper MIR; DRL = deeper retinal layer; EDV = end diastolic velocity; FAZ = foveal avascular zone; GO = Graves ophthalmopathy; MAR = macrovascular; MIR = microvascular; OCT = optical coherence tomography; OCTA = optical coherence tomography angiography; RI = resistance index; ROC = receiver operating characteristic; SMIR = superficial MIR; SOV = superior ophthalmic vein; SRL = superficial retinal layer; SSADA = split-spectrum amplitude-decor-relation angiography; STMI = superficial TMI; TAO = thyroid-associated ophthalmology; TMI = total MIR.

Citing Articles

Graves ophthalmopathy a neglected comorbidity of graves' disease; a detailed investigation and management of sixty-eight patients in a tertiary healthcare center.

Akkus G, Ulas B, Binokay H, Odabas F, Soysal R, Ozcan A BMC Endocr Disord. 2025; 25(1):46.

PMID: 39972308 PMC: 11837582. DOI: 10.1186/s12902-025-01875-7.


OCTA evaluates changes in retinal microvasculature in renal hypertension patients.

Wang L, Wang J, Chen C, Kang M, Xu S, Wei H Sci Rep. 2024; 14(1):28910.

PMID: 39572632 PMC: 11582710. DOI: 10.1038/s41598-024-68690-3.


Microvascular alterations of the ocular surface and retina in connective tissue disease-related interstitial lung disease.

Chen L, Kang M, Wang J, Xu S, Chen C, Wei H Int J Ophthalmol. 2024; 17(10):1869-1879.

PMID: 39430022 PMC: 11422355. DOI: 10.18240/ijo.2024.10.14.


Optical coherence tomography angiography in thyroid associated ophthalmopathy: a systematic review.

Rajabi M, Sadeghi R, Abdol Homayuni M, Pezeshgi S, Hosseini S, Rajabi M BMC Ophthalmol. 2024; 24(1):304.

PMID: 39039451 PMC: 11265183. DOI: 10.1186/s12886-024-03569-5.


Comparison of macular and optic disc vessel density in thyroid orbitopathy: a comparative octa study.

Yildiz I, Nacaroglu S, Karabulut G, Fazil K, Altan C Int Ophthalmol. 2024; 44(1):178.

PMID: 38622472 DOI: 10.1007/s10792-024-03114-9.